uracil and Pregnancy
uracil has been researched along with Pregnancy in 50 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Cylindrospermopsin (CYN) is a toxin produced by a variety of fresh-water cyanobacterial species worldwide and induces significant adverse effects in both livestock and humans." | 1.40 | The course of toxicity in the pregnant mouse after exposure to the cyanobacterial toxin cylindrospermopsin: clinical effects, serum chemistries, hematology, and histopathology. ( Brix, A; Chernoff, N; Gage, MI; Hill, D; Malarkey, DE; Rogers, EH; Schmid, JE; Travlos, GS; Zehr, RD, 2014) |
| "3 and 3 μg/kg) during pregnancy causes toxic effects and impairs gestation in rats." | 1.39 | Oral exposure to cylindrospermopsin in pregnant rats: reproduction and foetal toxicity studies. ( Araújo Moura Lemos, TM; Barbosa, PF; Caldas de Queiroz, E; Costa de Arruda, AC; Kujbida, P; Matias de Lima Costa, HT; Oliveira, CN; Pinto, E; Schwarz, A; Sibaldo de Almeida, C, 2013) |
| " Adverse effects of CYN were monitored up to 7 weeks post-dosing by clinical examination, histopathology, biochemistry and gene expression." | 1.37 | Toxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsin. ( Bradfield, CA; Chernoff, N; Gage, MI; Jaskot, RH; Liu, Y; Malarkey, DE; Richards, JH; Rogers, EH; Rosen, MB; Schmid, JE; Wood, CR; Zehr, RD, 2011) |
| " Analysis indicates no adverse effects on litter size, fetal weight, or incidence of anomalies." | 1.34 | The cyanobacterial toxin, cylindrospermopsin, induces fetal toxicity in the mouse after exposure late in gestation. ( Chernoff, N; Falconer, IR; Gage, MI; Humpage, AR; Marr, M; Rogers, EH; Zehr, RD, 2007) |
| " EMV tested negative for genotoxic activity, and except for decreased feed consumption at the high dose (160 mg/kg/day), with resultant decreases in maternal and fetal body weights, EMV produced no adverse effects in a complete range of reproductive toxicology experiments performed on rats and rabbits." | 1.31 | Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. ( Barry, DW; Blum, MR; Borroto-Esoda, K; Endoh, R; Furman, P; Grizzle, TB; Moxham, C; Niwa, T; Painter, GR; Sommadossi, J; Szczech, GM; Yamamoto, M, 2000) |
| "Three types of anal fissures are established." | 1.30 | [Acute anal fissures in puerperants]. ( Sariev, AA, 1999) |
| "A method has been developed for local treatment of endometritis with Dioxicol ointment, which promoted a more rapid recovery of the patients." | 1.28 | [Use of multicomponent ointments on a hydrophilic base in the prevention and treatment of postpartum endometritis]. ( Isaeva, AD; Maslova, SP; Poliakova, IL; Tamm, TI, 1989) |
Research
Studies (50)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (60.00) | 18.7374 |
| 1990's | 7 (14.00) | 18.2507 |
| 2000's | 4 (8.00) | 29.6817 |
| 2010's | 7 (14.00) | 24.3611 |
| 2020's | 2 (4.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Liu, W | 1 |
| Chen, L | 1 |
| Miao, K | 1 |
| You, Y | 1 |
| Li, J | 1 |
| Lu, J | 1 |
| Zhang, Y | 1 |
| Venter, WDF | 1 |
| Moorhouse, M | 1 |
| Sokhela, S | 1 |
| Fairlie, L | 1 |
| Mashabane, N | 1 |
| Masenya, M | 1 |
| Serenata, C | 1 |
| Akpomiemie, G | 1 |
| Qavi, A | 1 |
| Chandiwana, N | 1 |
| Norris, S | 1 |
| Chersich, M | 1 |
| Clayden, P | 1 |
| Abrams, E | 1 |
| Arulappan, N | 1 |
| Vos, A | 1 |
| McCann, K | 1 |
| Simmons, B | 1 |
| Hill, A | 1 |
| Sibaldo de Almeida, C | 1 |
| Costa de Arruda, AC | 1 |
| Caldas de Queiroz, E | 1 |
| Matias de Lima Costa, HT | 1 |
| Barbosa, PF | 1 |
| Araújo Moura Lemos, TM | 1 |
| Oliveira, CN | 1 |
| Pinto, E | 1 |
| Schwarz, A | 1 |
| Kujbida, P | 1 |
| Tian, YJ | 1 |
| Luo, N | 1 |
| Chen, NN | 1 |
| Lun, YZ | 1 |
| Gu, XY | 1 |
| Li, Z | 1 |
| Ma, Q | 1 |
| Zhou, SS | 1 |
| Chernoff, N | 3 |
| Rogers, EH | 3 |
| Zehr, RD | 3 |
| Gage, MI | 3 |
| Travlos, GS | 1 |
| Malarkey, DE | 2 |
| Brix, A | 1 |
| Schmid, JE | 2 |
| Hill, D | 1 |
| Trivedi, DK | 1 |
| Iles, RK | 1 |
| Martiniova, L | 1 |
| Field, MS | 1 |
| Finkelstein, JL | 1 |
| Perry, CA | 1 |
| Stover, PJ | 1 |
| Bradfield, CA | 1 |
| Liu, Y | 1 |
| Jaskot, RH | 1 |
| Richards, JH | 1 |
| Wood, CR | 1 |
| Rosen, MB | 1 |
| CANTAROW, A | 1 |
| WILLIAMS, TL | 1 |
| PASCHKIS, KE | 1 |
| Babadzhanov, BD | 1 |
| Teshaev, OR | 1 |
| Humpage, AR | 1 |
| Falconer, IR | 1 |
| Marr, M | 1 |
| Manzke, H | 1 |
| Spreter von Kreudenstein, P | 1 |
| Dörner, K | 1 |
| Kruse, K | 1 |
| Jakobs, C | 2 |
| Sweetman, L | 1 |
| Nyhan, WL | 1 |
| Gruenke, L | 1 |
| Craig, JC | 1 |
| Wadman, SK | 1 |
| Arnaud, MJ | 1 |
| Bracco, I | 1 |
| Sauvageat, JL | 1 |
| Clerc, MF | 1 |
| Feldberg, RS | 1 |
| Bowie, D | 1 |
| Smart, TG | 1 |
| Morimoto, T | 1 |
| Sasa, M | 1 |
| Monden, Y | 1 |
| Sakai, S | 1 |
| Hirota, K | 1 |
| Sawada, M | 1 |
| Sajiki, H | 1 |
| Sako, M | 1 |
| Scatena, CD | 1 |
| Adler, S | 1 |
| Sariev, AA | 1 |
| Szczech, GM | 1 |
| Furman, P | 1 |
| Painter, GR | 1 |
| Barry, DW | 1 |
| Borroto-Esoda, K | 1 |
| Grizzle, TB | 1 |
| Blum, MR | 1 |
| Sommadossi, J | 1 |
| Endoh, R | 1 |
| Niwa, T | 1 |
| Yamamoto, M | 1 |
| Moxham, C | 1 |
| Viana, M | 1 |
| Aruoma, OI | 1 |
| Herrera, E | 1 |
| Bonet, B | 1 |
| Cheonis, N | 1 |
| Forsthoefel, PF | 1 |
| Williams, ML | 1 |
| Arimura, H | 1 |
| König, J | 2 |
| Meier-Dörzenbach, ED | 1 |
| Menge, HG | 1 |
| Müller, H | 1 |
| Padberg, G | 1 |
| Petersen-Knoche, C | 1 |
| Schäfer, H | 1 |
| Benakis, A | 1 |
| Rey, C | 1 |
| Sekiguchi, M | 1 |
| Hayakawa, H | 1 |
| Makino, F | 1 |
| Tanaka, K | 1 |
| Okada, Y | 1 |
| Danilov, MA | 1 |
| Makarian, OA | 1 |
| Stellaard, F | 1 |
| Smit, LM | 1 |
| van Vugt, JM | 1 |
| Duran, M | 1 |
| Berger, R | 1 |
| Rovers, P | 1 |
| Isaeva, AD | 1 |
| Maslova, SP | 1 |
| Tamm, TI | 1 |
| Poliakova, IL | 1 |
| Adam, D | 1 |
| Schaffert, W | 1 |
| Marget, W | 1 |
| Bochert, G | 1 |
| Mewes, P | 1 |
| Krowke, R | 1 |
| Bariliak, IR | 2 |
| Alekhina, TN | 2 |
| Kosmachevskaia, EA | 1 |
| Chebotar', NA | 1 |
| Aivazian, TA | 1 |
| Schneider, EL | 1 |
| Stanbridge, EJ | 1 |
| Epstein, CJ | 1 |
| Golbus, M | 1 |
| Abbo-Halbasch, G | 1 |
| Rodgers, G | 1 |
| Worden, AN | 1 |
| Noel, PR | 1 |
| Mawdesley-Thomas, LE | 1 |
| Palmer, AK | 1 |
| Fletcher, MA | 1 |
| Dyban, AP | 1 |
| Gutová, M | 1 |
| Elis, J | 1 |
| Rasková, H | 1 |
| Kravets, MG | 1 |
| Fleĭshman, RP | 1 |
| Osinskiĭ, VV | 1 |
| Rolenkova, GA | 1 |
| Smahel, O | 1 |
| Cernoch, A | 1 |
| Grafnetterová, J | 1 |
| Grafnetter, D | 1 |
| Jedlicka, V | 1 |
| Schück, O | 1 |
| Smahelová, E | 1 |
| Gulyas, BJ | 1 |
| Daniel, JC | 1 |
| Saksena, SK | 1 |
| Chaudhury, RR | 1 |
| Monakhov, BV | 1 |
| Miuller, NR | 1 |
| Iaremenko, KV | 1 |
| Belayev, DK | 1 |
| Korochkin, LI | 1 |
| Maksimovsky, LF | 1 |
| Golubitsa, AN | 1 |
| Wilson, JG | 2 |
| Jordan, RL | 2 |
| Schumacher, H | 1 |
| Schumacher, HJ | 1 |
Clinical Trials (3)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Changes in Weight and Body Composition After Switch to Dolutegravir/Lamivudine Compared to Continued Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed HIV Infection: A Randomized Open-label Superiority Trial: AVERTAS-1[NCT04904406] | Phase 4 | 95 participants (Anticipated) | Interventional | 2020-10-22 | Recruiting | ||
| WRHI 060 (ADVANCE): A Randomised, Phase 3 Non-inferiority Study of DTG + TAF + FTC Compared With DTG + TDF + FTC and EFV + TDF + FTC in Patients Infected With HIV-1 Starting First-line Antiretroviral Therapy - Extension to 192 Weeks[NCT03122262] | Phase 3 | 1,110 participants (Actual) | Interventional | 2017-01-16 | Completed | ||
| Can the Weight Gain Associated With Use of Integrase Strand Inhibitors be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF in Patients Living With HIV? (DeLiTE)[NCT04665375] | Phase 4 | 25 participants (Anticipated) | Interventional | 2021-04-26 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Reviews
2 reviews available for uracil and Pregnancy
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[Some current problems of experimental teratology].
Topics: Abnormalities, Drug-Induced; Animals; Chick Embryo; Female; Hypoxia; Methods; Mice; Pregnancy; Rabbi | 1967 |
Trials
2 trials available for uracil and Pregnancy
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; CD4 Lymphocyte Count; Drug Therapy | 2019 |
Other Studies
47 other studies available for uracil and Pregnancy
| Article | Year |
|---|---|
Identification and validation of diagnostic biomarkers for intrahepatic cholestasis of pregnancy based on untargeted and targeted metabolomics analyses of urine metabolite profiles.
Topics: Biomarkers; Cholestasis, Intrahepatic; Female; Humans; Metabolomics; Pregnancy; Quality of Life; Ura | 2023 |
Oral exposure to cylindrospermopsin in pregnant rats: reproduction and foetal toxicity studies.
Topics: Administration, Oral; Alkaloids; Animals; Bacterial Toxins; Cyanobacteria Toxins; Drug Evaluation, P | 2013 |
Maternal nicotinamide supplementation causes global DNA hypomethylation, uracil hypo-incorporation and gene expression changes in fetal rats.
Topics: Animals; Betaine; Brain; Dietary Supplements; DNA; DNA Methylation; Down-Regulation; Epigenesis, Gen | 2014 |
The course of toxicity in the pregnant mouse after exposure to the cyanobacterial toxin cylindrospermopsin: clinical effects, serum chemistries, hematology, and histopathology.
Topics: Alkaloids; Animals; Bacterial Toxins; Cyanobacteria; Cyanobacteria Toxins; Dose-Response Relationshi | 2014 |
Shotgun metabolomic profiles in maternal urine identify potential mass spectral markers of abnormal fetal biochemistry - dihydrouracil and progesterone in the metabolism of Down syndrome.
Topics: Adult; Biomarkers; Chromatography, Reverse-Phase; Down Syndrome; Female; Fetus; Humans; Hydrophobic | 2015 |
Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects.
Topics: Animals; Deoxyuridine; Disease Models, Animal; Female; Folic Acid; Folic Acid Deficiency; Glycine Hy | 2015 |
Toxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsin.
Topics: Alkaloids; Animals; Bacterial Toxins; Biomarkers; Cyanobacteria; Cyanobacteria Toxins; Embryo Loss; | 2011 |
Uracil incorporation in liver RNA of young and pregnant rats and in RNA of fetal tissues and certain tumors.
Topics: Animals; Female; Fetus; Liver; Neoplasms; Pregnancy; Rats; RNA; Uracil | 1961 |
[Improvement of curative measures for peritonites of obstetric and gynecological etiology].
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Chlorampheni | 2004 |
The cyanobacterial toxin, cylindrospermopsin, induces fetal toxicity in the mouse after exposure late in gestation.
Topics: Alkaloids; Animals; Animals, Newborn; Bacterial Toxins; Cyanobacteria; Cyanobacteria Toxins; Embryo, | 2007 |
Quantitative measurements of the urinary excretion of creatinine, uric acid, hypoxanthine and xanthine, uracil, cyclic AMP, and cyclic GMP in healthy newborn infants.
Topics: Cesarean Section; Creatinine; Cyclic AMP; Cyclic GMP; Female; Fetal Blood; Humans; Hypoxanthines; In | 1980 |
Stable isotope dilution analysis of orotic acid and uracil in amniotic fluid.
Topics: Amniotic Fluid; Argininosuccinate Synthase; Chromatography, Liquid; Female; Gas Chromatography-Mass | 1984 |
Placental transfer of the major caffeine metabolite in the rat using 6-amino-5[N-formylmethylamino]1,3[Me-14C]-dimethyluracil administered orally or intravenously to the pregnant rat.
Topics: Administration, Oral; Animals; Autoradiography; Caffeine; Feces; Female; Injections, Intravenous; Ma | 1983 |
On the substrate specificity of a damage-specific DNA binding protein from human cells.
Topics: Carrier Proteins; DNA; DNA Repair; DNA-Binding Proteins; DNA, Viral; Female; Humans; In Vitro Techni | 1980 |
Thiocyanate ions selectively antagonize AMPA-evoked responses in Xenopus laevis oocytes microinjected with rat brain mRNA.
Topics: Alanine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Chemistry; Cell Me | 1993 |
[Improvement of clinical symptoms by UFT and TAM and a case of bone metastasis from breast carcinoma during pregnancy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Hum | 1994 |
Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
Topics: Antimetabolites, Antineoplastic; Cell Division; Drug Design; Enzyme Inhibitors; Female; Humans; Neov | 1997 |
Characterization of a human-specific regulator of placental corticotropin-releasing hormone.
Topics: Activating Transcription Factor 2; Base Sequence; Binding Sites; Corticotropin-Releasing Hormone; Cy | 1998 |
[Acute anal fissures in puerperants].
Topics: Actihaemyl; Acute Disease; Anti-Ulcer Agents; Cicatrix; Female; Fissure in Ano; Follow-Up Studies; G | 1999 |
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Bone Marrow; Dogs; Female; Fetus; Guinea Pigs; HIV-1; Humans; Liver; Macac | 2000 |
Oxidative damage in pregnant diabetic rats and their embryos.
Topics: Adenine; Animals; Congenital Abnormalities; Cytosine; Diabetes Mellitus, Experimental; DNA Adducts; | 2000 |
Emivirine: an NRTI that functions as an NNRTI.
Topics: Anti-HIV Agents; Cesarean Section; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Mic | 1999 |
The effects of 5-fluorouracil and 5-fluorodeoxyuridine used alone and in combination with normal nucleic acid precursors on development of mice in lines selected for low and high expression of Strong's luxoid gene.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Cell Survival; Drug Synergism; Female; Fetal Deat | 1975 |
Induction of antiviral activity in vivo and in vitro by human placenta ribonucleic acid treated with nitrous acid.
Topics: Adenine; Animals; Cell Division; Cell Line; Cytosine; Female; Guanine; Humans; Hypoxanthines; Interf | 1976 |
[Toxicologic study on the antihypertensive agent urapidil].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Body Weight; Dogs; Drug Tolerance; Female; I | 1977 |
Autoradiographic studies of the distribution of 14C-uracil and 14C-piperazine urapidil in male mice and pregnant mice.
Topics: Animals; Autoradiography; Female; Male; Mice; Piperazines; Pregnancy; Time Factors; Tissue Distribut | 1977 |
A human enzyme that liberates uracil from DNA.
Topics: Cell Line; Deoxyribonucleases; DNA, Viral; Escherichia coli; Female; Humans; Kinetics; Placenta; Pre | 1976 |
[Treatment of cows with puerperal endometritis].
Topics: Animals; Cattle; Drug Combinations; Emulsions; Female; Mastitis, Bovine; Neomycin; Penicillins; Preg | 1977 |
The first prenatal diagnosis of dihydropyrimidine dehydrogenase deficiency.
Topics: Amniotic Fluid; Dihydrouracil Dehydrogenase (NADP); Female; Humans; Metabolism, Inborn Errors; Oxido | 1991 |
[Use of multicomponent ointments on a hydrophilic base in the prevention and treatment of postpartum endometritis].
Topics: Acetanilides; Anti-Infective Agents, Local; Bacterial Infections; Drug Combinations; Endometritis; E | 1989 |
Enhanced in vitro phagocytosis of Listeria monocytogenes by human monocytes in the presence of ampicillin, tetracycline, and chloramphenicol.
Topics: Adult; Ampicillin; Bacteriological Techniques; Cells, Cultured; Centrifugation, Density Gradient; Ch | 1974 |
Labelling of RNA and DNA moieties of mammalian embryos in-vivo by 14 C-U-glucose and 32 P-orthophosphate.
Topics: Animals; Carbon Isotopes; Deoxyribonucleotides; DNA; Embryo, Mammalian; Female; Glucose; Hydrolysis; | 1973 |
[Effect of pentoxyl on the intrauterine development of rats].
Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Gestational Age; Immobilization; In | 1973 |
[The harmful effect of 4-methyluracil on rat embryogenesis under conditions of maternal stress].
Topics: Abnormalities, Drug-Induced; Animals; Cryptorchidism; Female; Hydronephrosis; Kidney; Male; Pregnanc | 1968 |
[Hysterographic studies in complex treatment of pregnant women with threatened abortion].
Topics: Abortion, Threatened; Diathermy; Estrogens; Female; Humans; Hysterosalpingography; Magnesium Sulfate | 1974 |
Mycoplasma contamination of cultured amniotic fluid cells: potential hazard to prenatal chromosomal diagnosis.
Topics: Amniocentesis; Amniotic Fluid; Cells, Cultured; Chromosome Aberrations; Electrophoresis, Polyacrylam | 1974 |
Feeding studies on lenacil in the rat and dog.
Topics: Animals; Appetite; Body Weight; Cyclohexanes; Diet; Dogs; Female; Herbicides; Liver; Male; Organ Siz | 1974 |
[Stimulating effect of pentoxyl on the mitotic activity of embryonic cells].
Topics: Animals; Cornea; Female; Kidney; Liver; Mitosis; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred St | 1972 |
Teratogenic effect of 6-azauridine in rats.
Topics: Abnormalities, Drug-Induced; Animals; Female; Pregnancy; Rats; Triazines; Uracil | 1971 |
[A case of dopan poisoning].
Topics: Adult; Female; Humans; Nitrogen Mustard Compounds; Pregnancy; Uracil | 1971 |
Results of clinical, pharmacokinetic, and pharmacodynamic studies of 6-azauridine.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Blood Cell Count; Blood Proteins; Bone | 1971 |
Incorporation of labeled nucleic acid and protein precursors by diapausing and nondiapausing blastocysts.
Topics: Alanine; Animals; Autoradiography; Caniformia; Carbon Isotopes; Dactinomycin; DNA; Embryo Implantati | 1969 |
The antifertility effect of 2', 3', 5'-tri-0-acetyl-6-azauridine. II. In rabbits.
Topics: Abortion, Induced; Acetates; Administration, Oral; Animals; Female; Ovulation; Pregnancy; Rabbits; T | 1970 |
[Results of experiments with the effect of methyluracil on pregnant rats and embryos].
Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Male; Pregnancy; Pregnancy, Animal; | 1967 |
Microelectrophoretic investigation of RNA base composition in the nerve cells of the N. supraopticus in the albino rat at different stages of the estrous cycle.
Topics: Adenine; Animals; Electrophoresis; Estrus; Female; Hypothalamus; Nerve Tissue; Nucleotides; Pregnanc | 1968 |
Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. I. Biological aspects.
Topics: Abnormalities, Drug-Induced; Animals; Carbon Isotopes; Carbon Tetrachloride Poisoning; Drug Synergis | 1969 |
Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. II. Biochemical aspects.
Topics: Animals; Carbon Isotopes; Depression, Chemical; DNA; Drug Synergism; Embryo, Mammalian; Extraembryon | 1969 |